会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Polypeptides, their production and use
    • 多肽,其生产和使用
    • US06794491B1
    • 2004-09-21
    • US09576290
    • 2000-05-23
    • Shuji HinumaYugo HabataYuji KawamataMasaki HosoyaRyo FujiiShoji FukusumiChieko Kitada
    • Shuji HinumaYugo HabataYuji KawamataMasaki HosoyaRyo FujiiShoji FukusumiChieko Kitada
    • C07K14475
    • C07H21/04A61K38/00C07K14/575C07K14/705C07K14/72C07K16/28
    • The present invention relates to the ligand polypeptide for the human pituitary- and mouse pancreas-derived G protein-coupled receptor proteins. The ligand polypeptide or the DNA which codes for the ligand polypeptide can be used for (1) development of medicines such as pituitary function modulators, central nervious system function modulators, and pancreatic function modulators, and (2) development of receptor binding assay systems using the expression of recombinant receptor proteins and screening of pharmaceutical candidate compounds. In particular, by the receptor binding assay systems utilizing the expression of recombinant G protein-coupled receptor proteins in accordance with the invention, agonists and antagonists of G protein-coupled receptors which are specific to human and other warm-blooded animals can be screened and the agonists or antagonists obtained can be used as therapeutic and prophylactic agents for various diseases.
    • 本发明涉及用于人垂体和小鼠胰腺衍生的G蛋白偶联受体蛋白质的配体多肽。配体多肽或编码配体多肽的DNA可用于(1)开发诸如垂体的药物 功能调节剂,中枢神经系统功能调节剂和胰腺功能调节剂,以及(2)使用重组受体蛋白质的表达和药物候选化合物的筛选开发受体结合测定系统。特别地,通过受体结合测定系统利用表达 根据本发明的重组G蛋白偶联受体蛋白质,可以筛选对人类和其他温血动物特异性的G蛋白偶联受体的激动剂和拮抗剂,并且所获得的激动剂或拮抗剂可用作治疗和预防 各种疾病的代理
    • 9. 发明授权
    • G-protein coupled receptor protein and a DNA encoding the receptor
    • G蛋白偶联受体蛋白和编码受体的DNA
    • US6114139A
    • 2000-09-05
    • US513974
    • 1995-09-14
    • Shuji HinumaMasaki HosoyaRyo FujiiTetsuya OhtakiShoji FukusumiKazuhiro Ohgi
    • Shuji HinumaMasaki HosoyaRyo FujiiTetsuya OhtakiShoji FukusumiKazuhiro Ohgi
    • C07K14/705C07K14/72C12N15/12C12Q1/68C12N5/10C12N15/63
    • C12Q1/6876C07K14/705C07K14/70571C07K14/723C12Q2600/158
    • DNA primers effective in screening G protein coupled receptor protein-encoding DNA fragments are provided. The primers which are complementary to nucleotide sequences that are in community with (homologous to) the nucleotide sequences encoding amino acid sequences corresponding to or near the first membrane-spanning domain or the sixth membrane-spanning domain each of known various G protein coupled receptor proteins were designed and synthesized. Methods of amplifying G protein coupled receptor protein-encoding DNAs using the above DNA primers, and novel target G protein coupled receptor protein-encoding DNAs are also provided. Screening of DNA libraries can be efficiently carried out. Human pituitary gland or amygdala-derived and mouse pancreas-derived G protein coupled receptor proteins, etc. or salts thereof, partial peptides thereof, DNAs coding for the above G protein coupled receptor proteins, processes for producing the above G protein coupled receptor proteins, methods of determining ligands for the above G protein coupled receptor proteins, methods of screening compounds that inhibit the binding between the ligand and the G protein coupled receptor proteins or screening kits therefor, compounds or salts thereof obtained by the above screening method or the screening kit, pharmaceutical compositions containing the above compounds or salts thereof, and antibodies against the above protein coupled receptor proteins or partial peptides thereof are provided.
    • PCT No.PCT / JP95 / 01599 Sec。 371 1995年9月14日第 102(e)1995年9月14日PCT PCT 1995年8月10日PCT公布。 出版物WO96 / 05302 日期1996年2月22日提供了有效筛选编码G蛋白偶联受体蛋白的DNA片段的DNA引物。 与与编码对应于或接近第一跨膜结构域或第六跨膜结构域的氨基酸序列的核苷酸序列(同源的)的核苷酸序列互补的引物,每个已知的各种G蛋白偶联受体蛋白 被设计和合成。 还提供了使用上述DNA引物扩增G蛋白偶联受体蛋白质编码DNA的方法,以及新的靶向G蛋白偶联受体蛋白质编码DNA。 可以有效地进行DNA文库的筛选。 人类垂体腺或来自扁桃体的小鼠胰腺衍生的G蛋白偶联受体蛋白等,或其盐,其部分肽,编码上述G蛋白偶联受体蛋白质的DNA,用于产生上述G蛋白偶联受体蛋白质的方法, 确定上述G蛋白偶联受体蛋白质的配体的方法,筛选抑制配体和G蛋白偶联受体蛋白质或其筛选试剂盒之间的结合的化合物的方法,通过上述筛选方法获得的化合物或其盐或筛选试剂盒 提供含有上述化合物或其盐的药物组合物和针对上述蛋白质偶联受体蛋白质或其部分肽的抗体。